RT @uptoTate: “Let’s consider treating nr-ax SpA and axSpA as serious, similar entities for better treatment options
Tweet Content
“Let’s consider treating nr-ax SpA and axSpA as serious, similar entities for better treatment options for our patients.” Dr. D. Poddubnyy discussing EXCEED study results and extrapolation of data. #EULAR2020 @RheumNow
Show on Archive Page
On
Display in Search Results
On